peptide elongation factor 2 has been researched along with Diabetes Mellitus, Type 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choudhury, GG; Kasinath, BS; Mariappan, MM; Sataranatarajan, K; Shetty, M | 1 |
1 other study(ies) available for peptide elongation factor 2 and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Glycogen synthase kinase 3beta is a novel regulator of high glucose- and high insulin-induced extracellular matrix protein synthesis in renal proximal tubular epithelial cells.
Topics: Adaptor Proteins, Signal Transducing; Animals; Carrier Proteins; Cell Cycle Proteins; Cell Line, Transformed; Diabetes Mellitus, Type 2; Epithelial Cells; Eukaryotic Initiation Factor-2B; Eukaryotic Initiation Factor-4E; Eukaryotic Initiation Factors; Fibronectins; Glucose; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hypertrophy; Hypoglycemic Agents; Insulin; Kidney Diseases; Kidney Tubules, Proximal; Laminin; Mice; Mitogen-Activated Protein Kinase 1; Peptide Elongation Factor 2; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Protein Biosynthesis; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; Sweetening Agents; Time Factors; TOR Serine-Threonine Kinases | 2008 |